DCN Dx Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
DCN Dx is a mid-sized biotechnology firm based in Carlsbad, California, that specializes in the contract development of rapid point-of-care tests. Its core work centers on rapid immunoassay development across lateral flow, flow-through, and microfluidic formats, with capabilities in high-sensitivity assays, quantification, multiplexing, and reader integration. The company acts as an end-to-end partner, integrating assay development with device design to deliver fully assembled, user-centric diagnostic products. Its ISO 9001:2015 compliant development process supports close coordination between assay and device pathways, aiming to improve the likelihood of commercial success. In addition to development services, DCN Dx provides training, consulting, and materials for rapid assay development, and in January 2026 launched a prospective biospecimen collections service.